In 3Q06, there were 5.3 procedures per installed device per month. That’s 1.2 procedures per week.
Even after allowing for summer vacations, the only way device utilization can possibly be that low is if some docs are letting their devices collect dust in a closet.
[Revenue in the quarter was up 18% from 3Q06 and 58% from 4Q05, but still rather anemic in terms of procedures per installed system, which is IMO a good gauge for the traction THRM is gaining at this stage of the company’s development. As I do not believe that the company’s device works, I am waiting for an opportune to sell short. CC at 4:30 pm ET; feedback is warmly welcomed from anyone who listens.]
>> Company Achieves Record Revenue; Q4 Revenue and Net Income Each Increase by $5.4 Million Over Prior Year Period
HAYWARD, Calif., Feb. 13 /PRNewswire-FirstCall/ -- Thermage, Inc. (Nasdaq: THRM ), a leader in non-invasive tissue tightening in the aesthetic industry, today reported financial results for the fourth quarter and full year ended December 31, 2006.
Revenue for the quarter ended December 31, 2006 was $14.8 million, up 58% from $9.3 million for the quarter ended December 31, 2005. Gross profit increased to $10.7 million or 72.3% of revenue, for the quarter ended December 31, 2006, up from $5.9 million or 63.0% of revenue for the quarter ended December 31, 2005. The Company reported GAAP net income of $1.4 million with no income allocable to common stockholders for the quarter ended December 31, 2006, versus a net loss of $4.0 million, or $1.06 per share, for the quarter ended December 31, 2005. Non-GAAP net income for the fourth quarter of 2006 was $0.3 million, or $0.02 per share, compared to a net loss of $3.1 million, or $0.20 per share, for the prior year period.
"In the fourth quarter, we experienced strong revenue growth in both U.S. and international markets," said Stephen J. Fanning, Chairman, President and Chief Executive Officer. "U.S. revenue increased 69% and international revenue increased 47% as compared to the fourth quarter of 2005. Recurring revenue generated by our ThermaTips and other consumable products represented 74% of total revenue during the period.
"We are very pleased with the treatment tips, applications, and practice marketing tools we introduced to our customers in 2006," continued Mr. Fanning. "In 2007, we will focus on continuing to deliver new treatment tips and applications to our worldwide installed base of over 2,000 customers. We anticipate driving further leverage from our industry unique business model built predominantly on strong recurring revenue. In addition, we are committed to building lasting partnerships with our customers."
Revenue for the year ended December 31, 2006 was $54.3 million, up 34% from $40.7 million for the year ended December 31, 2005. Gross profit increased to $39.1 million, or 71.9% of revenue for the year ended December 31, 2006, up from $28.3 million, or 69.7% of revenue, for the year ended December 31, 2005. The Company reported a GAAP net loss of $3.9 million, or $0.60 per share, for the year ended December 31, 2006 versus a net loss of $8.2 million, or $2.25 per share, for the year ended December 31, 2005. Non- GAAP net loss for the years ended December 31, 2006 and 2005 was $1.2 million, or $0.07 per share, and $7.3 million, or $0.46 per share, respectively.
Guidance:
Management expects revenue for full year 2007 to be in a range of $65 million to $68 million, an increase of 20% to 25% over full year 2006.
For the full year 2007, we expect GAAP diluted earnings per share to be in a range of a net loss of $0.04 per share to net income of $0.03 per share. Non-GAAP diluted earnings per share are expected to be in a range of net income of $0.16 to $0.23 per share. The per share earnings amounts are based on fully diluted weighted average shares of 26 million.
Conference Call:
The conference call is scheduled to begin at 1:30 p.m. PST (4:30 p.m. EST) on February 13, 2007. The call will be broadcast live over the Internet hosted at the Investor Relations section of the Company's website at www.thermage.com. In addition, you may call to listen to the live broadcast: 800-257-1836 for domestic participants and 303-262-2143 for international participants. Participating in the call will be Stephen J. Fanning, Chairman, President and Chief Executive Officer, and Laureen DeBuono, Chief Financial Officer.
A taped replay of the conference call will also be available beginning approximately one hour after the call's conclusion and will remain accessible for seven days. This replay can be accessed by dialing 800-405-2236, Pass code 11077434# for domestic callers and 303-590-3000, Pass code 11077434# for international callers. An archived web cast will also be available at www.thermage.com.
About Thermage, Inc.
Thermage's innovative technology provides a unique non-invasive procedure designed to tighten and contour skin, significantly expanding the non-invasive aesthetic applications physicians can offer to the rapidly growing "anti- aging" market. For more information, call 1-510-259-7117 or visit www.thermage.com
Thermage, Inc. CONDENSED STATEMENTS OF OPERATIONS (in thousands of dollars, except share and per share data) (unaudited)
Three Months Ended Years Ended December 31, December 31, 2006 2005 2006 2005
Net revenue $14,751 $9,338 $54,320 $40,655 Cost of revenue 4,087 3,452 15,259 12,309
Gross margin 10,664 5,886 39,061 28,346
Operating expenses Sales and marketing 6,136 4,927 24,071 19,997 Research and development 2,510 2,365 9,639 8,908 General and administrative 2,628 1,913 9,973 7,414 Litigation settlement gain - - - (1,646)
Total operating expenses 11,274 9,205 43,683 34,673
Loss from operations (610) (3,319) (4,622) (6,327) Interest and other income 393 89 768 340 Interest and other expense 1,606 (809) (55) (1,549)
Income (loss) before income taxes and cumulative effect of change in accounting principle 1,389 (4,039) (3,909) (7,536) Provision for income taxes - - - -
Income (loss) before cumulative effect of change in accounting principle 1,389 (4,039) (3,909) (7,536)
Cumulative effect of change in accounting principle - - - (697)
Net income (loss) $1,389 $(4,039) $(3,909) $(8,233)
Income (loss) allocable to common stockholders $0 $(4,039) $(3,909) $(8,233)
Net income (loss) per share - basic and diluted: Before cumulative effect of change in accounting principle - - - $(2.06) Cumulative effect of change in accounting principle - - - (0.19)
Net income (loss) per share - basic and diluted $0.00 $(1.06) $(0.60) $(2.25)
Weighted average shares outstanding used in calculating net income (loss) per common share: Basic and diluted 13,578,831 3,802,128 6,561,648 3,664,990
Thermage, Inc NON-GAAP RECONCILIATION OF NET INCOME (LOSS) AND NET INCOME (LOSS) PER SHARE (in thousands, except share and per share data) (unaudited)
Three Months Ended Years Ended December 31, December 31, 2006 2005 2006 2005
GAAP net income (loss) $1,389 $(4,039) $(3,909) $(8,233)
Non-GAAP adjustments to net income (loss): Stock-based compensation (a) 855 187 3,517 456 Litigation settlement gain (b) - - - (1,646) Impact of change in fair value of preferred warrant liabilities (c) (1,912) 737 (837) 2,136 Total non-GAAP adjustments to net income (loss) (1,057) 924 2,680 946 Non-GAAP net income (loss) $332 $(3,115) $(1,229) $(7,287)
GAAP basic and diluted net income (loss) per share $0.00 $(1.06) $(0.60) $(2.25)
Non-GAAP adjustments to basic & diluted income (loss) per share: Stock-based compensation (a) 0.04 0.01 0.21 0.03 Litigation settlement gain (b) - - - (0.10) Impact of change in fair value of preferred warrant liabilities (c) (0.10) 0.05 (0.05) 0.14 Impact of higher weighted average shares due to assumed conversion of preferred shares (d) 0.07 0.81 0.37 $1.72 Non-GAAP basic net income (loss) per share $0.02 $(0.20) $(0.07) $(0.46)
Non-GAAP diluted net income (loss) per share $0.02 $(0.20) $(0.07) $(0.46)
Weighted average shares outstanding used in calculating non-GAAP basic net income (loss) per common share: 19,555,404 15,844,099 17,081,516 15,707,264
GAAP weighted average shares outstanding used in calculating net income (loss) per common share: 13,578,831 3,802,128 6,561,648 3,664,990 Adjustments to reflect assumed weighted average effect of conversion of preferred stock 5,976,573 12,041,971 10,519,868 12,042,274 Weighted average shares outstanding used in calculating non-GAAP basic net income (loss) per common share: 19,555,404 15,844,099 17,081,516 15,707,264
Adjustments to unvested common stock subject to repurchase 6,875 - - -
Adjustments for dilutive potential common stock 2,479,998 - - -
Weighted average shares outstanding used in calculating non-GAAP diluted net income per common share: 22,042,277 15,844,099 17,081,516 15,707,264
(a) Includes all employee and non-employee stock-based compensation charges (b) Includes litigation settlement gain recorded in June 2005 (c) Includes the impact of cumulative effect of change in accounting principle and subsequent adjustments related to the revaluation of the Company's preferred stock warrant liability during the period. (d) Assumes the conversion of the Company's convertible preferred stock into shares of common stock at the beginning of the period.
Thermage, Inc. CONDENSED BALANCE SHEETS (in thousands of dollars, except share and per share data) (Unaudited)
December 31, December 31, 2006 2005
ASSETS Current assets: Cash and cash equivalents $45,915 $10,121 Accounts receivable, net 3,285 2,857 Inventories, net 5,219 5,411 Prepaid expenses and other current assets 1,717 1,350
Total current assets 56,136 19,739
Restricted cash - 107 Property and equipment, net 3,638 4,073 Other assets 101 113
Total assets $59,875 $24,032
LIABILITIES, REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY Liabilities Accounts payable $1,398 $1,977 Accrued liabilities 7,372 4,774 Current portion of deferred revenue 1,151 1,188 Customer deposits 62 45 Current portion of borrowings - 808
Total current liabilities 9,983 8,792 Deferred rent, net of current portion 55 110 Other long-term liabilities - 107 Deferred revenue, net of current portion 716 610 Borrowings, net of current portion - 4,040 Preferred stock warrants liability - 3,937
Total liabilities 10,754 17,596
Redeemable convertible preferred stock, $0.001 par value: shares authorized: 10,000,000 and 26,350,000 shares at 2006 and 2005, respectively issued and outstanding: none and 12,042,274 shares at 2006 and 2005, respectively - 45,169
Stockholders' equity (deficit): Common stock, $0.001 par value: shares authorized: 100,000,000 and 29,100,000 shares at 2006 and 2005 issued and outstanding: 22,906,851 and 4,037,774 issued and outstanding 23 4 Additional paid-in capital 93,418 5,682 Deferred stock-based compensation (6) (3,541) Notes receivable from stockholders (125) (598) Accumulated deficit (44,189) (40,280)
Total stockholders' equity (deficit) 49,121 (38,733)
Total liabilities and stockholders' equity $59,875 $24,032 <<
Market Data 
Markets 
AI
